Michael Tirmonia, DO

Appointed
2018

Education & Fellowships

Residency - Cleveland Clinic
Internal Medicine
Cleveland, OH USA
1997

Internship - Botsford General Hospital
Rotating
Famington Hills, MI USA
1994

Medical Education - Ohio University
Athens, OH USA
1993

Undergraduate - Wittenberg University
Springfield, OH USA
1989

Specialty Interests

My interests at this time are multifaceted . I have a special interest in the outpatient and inpatient coordination of complex patients who often have been my patients for an upwards of 10 to 20 years . I am very passionate about the diligent and accurate coordination of my complex patients . I have been an early champion of transitional care. I perform coordinated care daily and I have felt that I have done it well with 21 plus years experience taking care of my patients in and out of the hospital setting. I believe it is so important to have had that continuity with my patients to facilitate excellent outcomes and prevent untimely readmissions . I am also passionate about preventive care with the prevention of cardiovascular related disease and also cancer . Again working closely with my colleagues in and out of the hospital setting has shown my peers that this interest in preventive medicine has been fruitful for my patients . I have been happy with the use of the Epic EMR system since my start with the CCF in May 2018. I believe it gives added helpful reminders to guide my patients with their preventive care needs at any age. I have a special interest in the treatment and coordination of care of the patient with CHF. I sit as the Chairman of the CHF committee within my predominant hospital in Canton at Mercy Medical Center. I have had that committee really show a real reduction in readmission with the disease process of CHF, I have helped through that committee begin various programs that have fostered better coordination of care with all patients who carry the diagnosis of CHF . The Meds to Beds program is one such program. I have had excellent collegial discussions with our chief of Cardiovascular Services Dr Sabe over my four plus years of leadership on that committee . He and I are passionate about quality within the department and also amongst the various specialties that routinely cardiac patients are entwined with. I am also very interested in leadership, as I have been in many years . I have held numerous positions as I do today. All the interest points towards quality care, patient experience, and economically sound medicine to benefit the patient . I want to explore leadership within the CCF with you in the APR session and further as I move on to finish my first full year as a staff member with the CCF.

See publications for Michael Tirmonia, DO.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 11/17/2018, Dr. Tirmonia has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.